Literature DB >> 24564002

Obesity: the 'huge' problem in cardiovascular diseases.

M Javed Ashraf1, Paramdeep Baweja2.   

Abstract

Obesity is an epidemic in the United States. It is an independent risk factor for cardiovascular diseases and associated with reduced life expectancy. The adverse effects are related to direct impact of obesity on cardiovascular system and indirectly through its influence on risk factors. Excessive accumulation of adipose tissue in the myocardium leads to structural and functional alteration. In addition, numerous hormones secreted by adipose tissue create pro-inflammatory and prothrombotic state. This predisposes to coronary heart disease, heart failure, and sudden death. Even those with normal weight but excessive body fat are at risk. Weight reduction and exercise are the main therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24564002      PMCID: PMC6179812     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  27 in total

Review 1.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

2.  Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients.

Authors:  C J Lavie; R V Milani
Journal:  Am J Cardiol       Date:  1997-02-15       Impact factor: 2.778

3.  Fatty infiltration: another restrictive cardiomyopathic pattern.

Authors:  J P Dervan; A Ilercil; P B Kane; C Anagnostopoulos
Journal:  Cathet Cardiovasc Diagn       Date:  1991-03

4.  Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity.

Authors:  Paul Poirier; Teri L Hernandez; Kathleen M Weil; Trudy J Shepard; Robert H Eckel
Journal:  Obes Res       Date:  2003-09

5.  Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.

Authors:  John A Batsis; Abel Romero-Corral; Maria L Collazo-Clavell; Michael G Sarr; Virend K Somers; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2008-08       Impact factor: 7.616

6.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

Review 7.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

8.  Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.

Authors:  Abel Romero-Corral; Justo Sierra-Johnson; Francisco Lopez-Jimenez; Randal J Thomas; Prachi Singh; Michal Hoffmann; Aynur Okcay; Josef Korinek; Robert Wolk; Virend K Somers
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-22

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  H C McGill; C A McMahan; G T Malcom; M C Oalmann; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more
  7 in total

1.  Validity of two brief physical activity questionnaires with accelerometers among African-American women.

Authors:  Rodney P Joseph; Colleen Keller; Marc A Adams; Barbara E Ainsworth
Journal:  Prim Health Care Res Dev       Date:  2015-07-16       Impact factor: 1.458

2.  There's no such thing as "healthy obesity".

Authors:  M Javed Ashraf
Journal:  Mo Med       Date:  2014 Jan-Feb

Review 3.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

4.  Exercise dose-response relationship with heart rate variability in individuals with overweight and obesity: protocol for a systematic review and meta-analysis of randomised controlled trials.

Authors:  Mukesh Kumar Sinha; G Arun Maiya; Ana Maria Moga; Shivashankar K N; Ravi Shankar N; Vaishali K
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

5.  The burden of behavioral risk factors for cardiovascular disease in Europe. A significant prevention deficit.

Authors:  Maria Vassilaki; Manolis Linardakis; Donna M Polk; Αnastas Philalithis
Journal:  Prev Med       Date:  2015-10-09       Impact factor: 4.018

Review 6.  Significance of Resveratrol in Clinical Management of Chronic Diseases.

Authors:  Awais Wahab; Kuo Gao; Caixia Jia; Feilong Zhang; Guihua Tian; Ghulam Murtaza; Jianxin Chen
Journal:  Molecules       Date:  2017-08-18       Impact factor: 4.411

Review 7.  Bile Acids as a New Type of Steroid Hormones Regulating Nonspecific Energy Expenditure of the Body (Review).

Authors:  P P Zagoskin; E I Erlykina
Journal:  Sovrem Tekhnologii Med       Date:  2020-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.